Autres langues AstraZeneca PLC Nasdaq Stockholm

Actions

AZN

GB0009895292

Produits pharmaceutiques

Marché Fermé - Nasdaq Stockholm 18:00:00 31/07/2026 Varia. 5j. Varia. 1 janv.
1 627,50 SEK -0,34% Graphique intraday de AstraZeneca PLC -1,36% -4,46%

Autres langues

12:29 EU Approves AstraZeneca and Daiichi Sankyo's Datroway for First-Line Triple-Negative Breast Cancer
10:55 Astrazeneca, Daiichi Sankyo's Breast Cancer Therapy Receives EU approval
10:50 Datroway® Approved in the Eu as Only Trop2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic Tnbc Who Are Not Candidates for Immunotherapy
10:50 AstraZeneca's and Daiichi's Datroway wins EU breast cancer approval
09:04 EU Approves AstraZeneca, Daiichi Sankyo's Datroway for Triple-negative Breast Cancer
30/07 Xencor Shares Rise After Settlement Deal With Alexion
30/07 UK's Robert Walters expects smaller loss and downplays AI impact on hiring
30/07 WINNERS & LOSERS: Rolls-Royce ups guide; Rentokil slumps
30/07 Sanofi drug pipeline worries, Dupixent dependence shake shares
30/07 Merck, Wellcome partner with global health group to make Ebola vaccine for clinical trials
29/07 Deutsche Bank cuts Diageo and Luceco
29/07 DKSH erweitert Partnerschaft mit Novartis für Blutdruckmedikamente in Korea
28/07 GSK Launches Cost-Saving Plan to Accelerate Drug Pipeline -- Update
28/07 GSK to invest £400 million in Britain over three years as it ramps up R&D efforts
28/07 Lepu Biopharma, AstraZeneca Cancer Drug Meets Phase 3 Survival Goal
28/07 AstraZeneca Kept at Buy as Berenberg Notes 'Upbeat' Q2 Earnings Call
28/07 Hong Kong Stocks Edge Higher Ahead of Central Bank Meetings; Keymed Biosciences Falls
28/07 Citi ups Admiral; Peel Hunt cuts Sabre
28/07 Keymed Biosciences' Gastric Cancer Drug Meets Phase 3 Goal; Shares Fall 5%
28/07 MORNING BRIEFING - Deutschland/Europa
28/07 Hong Kong-listed Keymed Biosciences' gastric cancer drug meets late-stage trial goals
27/07 Health Care Up Amid Deal Activity -- Health Care Roundup
27/07 Bolsas europeas se mantienen estables, debilidad de tecnológicas contrarresta optimismo sobre EEUU-Irán
27/07 European shares steady as tech weakness offsets US-Iran optimism
27/07 Uneinheitlich - Ölpreis-Rpückgang stützt - Schwacher Tech-Sektor
Aucun résultat pour cette recherche